SIGNET Healthcare Partners, a New York-based healthcare private equity firm, completed the investment in LAXAI, a provider of contract research, development, and manufacturing solutions to pharmaceutical and specialty chemical companies. Financial terms were not disclosed. "LAXAI has been a trusted partner in the pharmaceutical and specialty chemical space providing client focused contract research and development services.” SIGNET’s investment will enhance LAXAI’s infrastructure and further augment operations to help our customers and partners maximize innovation and productivity. "We are very pleased to welcome SIGNET as a partner to help accelerate growth and achieve our ambitious long-term objectives. We look forward to leveraging SIGNET’s knowledge and network as we continue to expand and enhance operations," Vamsi Maddipatla, LAXAI Chairman and Managing Director.